Close Menu
    What's Hot

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Litigation

    Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

    July 22, 2026

    South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

    July 22, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026

      UK Bulk Annuity Insurers’ Exposure to Private Credit Set To Remain Manageable

      July 20, 2026
      Milliman

      Competitive US Pension Risk Transfer Cost Decreased During June

      July 20, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

      July 22, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Q&A: Yona Chesner, Head of Pensions Investment, Cartwright Pension Trusts

      July 22, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Life Insurance Companies Continue To Offer Opportunities for Private Debt Despite Macro Uncertainty

    Life Insurance November 16, 2022By Greg Winterton
    Life insurance private debt
    Share
    Twitter LinkedIn Email

    High inflation, the spectre of a recession and an increase in the cost of borrowing could put pressure on many SMEs that have taken out floating rate loans from private debt shops or that are looking to restructure existing debt or take out additional loans in the coming twelve to 24 months. It’s an industry wide challenge that the private debt sector – by far the largest subset of the alternative credit market – will face in the short term.

    Some of the nuances of the life insurance industry may provide some kind of insulation from the coming storm. Life insurance companies tend to make more money in a rising interest rate environment because the premiums received from any new business they underwrite can be allocated to higher yielding investments; ergo, they are healthier counterparties for investors and lenders.

    Despite this benefit, however, this subset of the direct lending market remains an under resourced one. Dan Knipe, Founder and CIO of speciality lender and KKR portfolio company Kilter Finance, says that there is a perception issue amongst investors that is a touch misguided.

    “Investors tend to only see a handful of household names. This larger end of the insurance lending market is very efficient from a capital markets perspective as the issuers are generally listed and can tap the debt capital markets when they need to,” he said. “But below that, it’s super inefficient because private lending is out of scope for the investors in the large public bonds and traditional private lenders don’t have the familiarity with the balance sheet side of the insurance sector. When you look at the amount of capital across European and US life insurers, there’s in excess of $1.5trn worth of capital and surplus. The tail of potential borrowers for private debt solutions is really long.”

    Part of the reason that the insurance sector is less well served by private debt than, say, the manufacturing industry might be is because of the comparatively higher level of complication of the respective companies. Lenders to manufacturing or retail businesses, for example, understand where the revenue comes from, and they have a good sense of what needs to be done to engineer a recovery, if necessary. But life insurance companies are complicated businesses with additional layers of complexity.

    “A life insurer’s balance sheet is very large and materially different to businesses whose revenues are derived from the provision of services for a fee. It’s a heavily regulated sector, so debt underwriting, debt management and any debt workout requires specific and specialised experience and skills,” said Knipe. “Private debt markets are available to insurance services businesses that don’t need large balance sheets. For life insurers who have a material balance sheet the presence of complex regulatory, rating and accounting interactions opens up an interesting opportunity to earn excess returns as compared to lending to simpler businesses.”

    Investors looking at the life insurance sector as an alpha generator should also need to drill down on the differences in exposure to life and non-life carriers as Luca Tres, Head of EMEA Strategic Risk and Capital Life Solutions at Guy Carpenter, explains.

    “On the life side, catastrophe risk tends to be fairly limited (we witnessed this during the Covid-19 pandemic), but the asset risk component is usually more prominent than for property and casualty carriers because of the longer duration of the life insurance liabilities and the savings components that many life insurance policies have. Also, it’s very different to lend to a life insurance company with a traditional risk product mix and a conservative investment portfolio. And the jurisdiction of the borrower can have an important role itself, since capital requirements, investment and risk guidelines can be different.”

    Additionally, the wide range of debt financing opportunities in the life insurance market – reinsurance-based financing, senior bonds/loans, Tier 2 financing, RT1 financing, etc. – need to have the risk exposure analysed and understood.

    “These are all insurance lending structures, but the risk can differ materially depending on the type of financing. Also, insurance holding company financing versus financing a transaction at the operating company again has a different risk profile,” said Tres. “Insurance lending provides different risk/reward profiles suited to different investors’ needs in different parts of the credit cycle, so every situation needs to be analysed on a case-by-case basis.”

    Investors look to credit investing as a lower volatility yield generator that serves as a diversifier to public and private equity exposure. Tres says that in times of economic uncertainty, life insurance companies can provide a defensive element, too.

    “Lending to highly regulated businesses like life insurance companies can make a material difference compared to non-regulated businesses. While one could argue that asset risk is one of the largest risks (especially in a volatile macroeconomic context) for insurance companies, in a stressed context, the regulation that insurers are forced to comply with by definition puts lenders in a better position compared to many other industries. In Europe for example, Solvency II forces insurance companies to have capital covering the 99.5% worst case scenario; if you exclude insurance and banking activities – where do you see anything that’s comparable?”

    For Knipe, those potentially interested in accessing the life insurance space for fixed income returns need to get comfortable with the potential correlation of returns in the space to the broader fixed income and equity markets, but he agrees that the regulatory situation can act as a defensive support and urges investors to take more notice.

    “You can’t say that there is a zero correlation between life insurance companies and financial markets – there is always some level of correlation,” said Knipe. “But the regulatory framework tends to isolate an investment in a life insurer from many of the cyclical impacts you might see in other sectors. We’d encourage investors to take some time to understand the large opportunity set in the space. It’s an opportunity to access a diversifying return stream to complement a broader private credit portfolio.”

    2022 - November Alternative Credit Volume 1 Issue 7 - November 2022
    Share. Twitter LinkedIn Email

    Related Posts

    UK Equity Release Market Waits on Fourth Quarter for Potentially Market-Altering Change

    June 24, 2026By Greg Winterton

    Japanese Life Insurance Industry Offering the Capital Markets Plenty of Opportunities

    May 28, 2026By Greg Winterton

    Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

    April 22, 2026By Greg Winterton

    EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

    March 25, 2026By Greg Winterton
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.